Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 4 1Phase 3 1Phase 1/2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 117INDUSTRY 78NIH 14NETWORK 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Stomach Neoplasms 8Breast Neoplasms 8Carcinoma, Non-Small-Cell Lung 5Triple Negative Breast Neoplasms 4Small Cell Lung Carcinoma 4Neoplasms 4Multiple Myeloma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Parasomnias 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Melanoma 2Lymphoma 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Head and Neck Neoplasms 2HIV Infections 2Fatigue 2Erectile Dysfunction 2Carcinoma, Hepatocellular 2Vitamin D Deficiency 1Uveal Melanoma 1Urinary Bladder Neoplasms 1Untreated Advanced Non-small Cell Lung Cancer 1Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1

Interventions

Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER_GOV × Myelodysplastic Syndromes × Clear all
NCT06299462 2025-02-25

PTCy and ATG for MSD and MUD Transplants

Instituto Nacional de Cancer, Brazil

Phase 1/2 Recruiting
50 enrolled
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡